Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000318154-20-000007
Filing Date
2020-01-27
Accepted
2020-01-24 19:16:18
Documents
18
Period of Report
2019-11-21
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A amgn-20198kaotezla.htm   iXBRL 8-K/A 63258
2 EX-99.1 ex991specialpurposesta.htm EX-99.1 123567
3 EX-99.2 ex992specialpurposesta.htm EX-99.2 193541
4 EX-99.3 ex993amgn-2019otezlaxe.htm EX-99.3 386469
5 EX-99.4 ex994consentofaccounti.htm EX-99.4 7442
  Complete submission text file 0000318154-20-000007.txt   1046105

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20191121.xsd EX-101.SCH 5299
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20191121_cal.xml EX-101.CAL 614
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20191121_def.xml EX-101.DEF 17875
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20191121_lab.xml EX-101.LAB 38962
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20191121_pre.xml EX-101.PRE 19583
14 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20198kaotezla_htm.xml XML 8823
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37702 | Film No.: 20546799
SIC: 2836 Biological Products, (No Diagnostic Substances)